GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

GLP-1 class drugs like Zepbound and Mounjaro form part of a larger group of products like Wegovy and Ozempic from Novo ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Users on TikTok have touted the benefits of taking berberine supplements, claiming benefits for weight loss, heart health and ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...

Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...

A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.